HUBUNGAN KEPATUHAN PENGOBATAN ANTIHIPERTENSI DENGAN RISIKO KARDIOVASKULAR PADA PASIEN HIPERTENSI PUSKESMAS TELAGA MURNI

  • Destya Antarini Program Studi Sarjana Farmasi, Fakultas Ilmu Kesehatan, Universitas Medika Suherman, Bekasi, Indonesia
  • Marselina Marselina Program Studi Sarjana Farmasi, Fakultas Ilmu Kesehatan, Universitas Medika Suherman, Bekasi, Indonesia
  • Nuzul Gyanata Adiwisastra Program Studi Sarjana Farmasi, Fakultas Ilmu Kesehatan, Universitas Medika Suherman, Bekasi, Indonesia
  • Ninik Suparmi Program Studi Sarjana Farmasi, Fakultas Ilmu Kesehatan, Universitas Medika Suherman, Bekasi, Indonesia
Keywords: Hypertension, adherence, MARS-5, MPR, Health Center, Cardiovascular

Abstract

Hypertension is a major risk factor for cardiovascular disease, with its prevalence continuously increasing in the community. Adherence to antihypertensive therapy plays a crucial role in controlling blood pressure and preventing cardiovascular complications. However, evidence on the relationship between medication adherence and cardiovascular risk remains inconsistent, especially in primary healthcare settings. This study was conducted at Telaga Murni Primary Health Center – Cikarang, where hypertension is among the ten most common diseases. The study aimed to determine the relationship between adherence to antihypertensive therapy and cardiovascular risk among hypertensive patients. This research employed a quantitative analytic design with a cross-sectional approach involving 85 hypertensive patients selected through purposive sampling. Adherence was assessed using the Medication Adherence Report Scale (MARS-5) and Medication Possession Ratio (MPR), while cardiovascular risk was evaluated using the ASCVD Risk Estimator. Data were analyzed using the Chi-Square test, linearity test, and Odds Ratio calculation. The results showed that most patients were adherent (MARS-5 = 91.8%; MPR = 72.9%) and had low cardiovascular risk (52.9%). There was a significant relationship between adherence and cardiovascular risk for both MARS-5 (p=0.041) and MPR (p=0.049), although linear correlation was observed only in MARS-5 (p=0.012). Adherent patients had a higher likelihood of having a lower cardiovascular risk compared to non-adherent patients. In conclusion, adherence to antihypertensive therapy was associated with cardiovascular risk among hypertensive patients. Continuous education and regular monitoring are essential to maintain patient adherence and prevent increased cardiovascular risk.

References

Abdullah, F., Harahap, D., & Putri, A. (2021). Faktor-faktor yang memengaruhi kepatuhan pasien hipertensi di layanan primer Indonesia. Jurnal Farmasi Klinis Indonesia, 10(2), 150–158.

AlGhurair, S. A., Hughes, C. A., Simpson, S. H., & Guirguis, L. M. (2012). A systematic review of patient self-reported barriers of adherence to antihypertensive medications using the World Health Organization Multidimensional Adherence Model. Journal of Clinical Hypertension, 14(12), 877-886.

Aman, A. M., Soewondo, P., Soelistijo, S. A., Arsana, P. M., Wismandari, Zufry, H., & Rosandi, R. (2019). Pedoman pengelolaan dislipidemia di Indonesia 2019. Perkumpulan Endokrinologi Indonesia, 1–65.

Andini, N. Z., Marselina, M. S. D., & Prakoso, A. D. (2024). Faktor-faktor yang mempengaruhi kepatuhan pasien dalam menggunakan obat hipertensi di Puskesmas Cikarang. Cakrawala Medika: Journal of Health Sciences, 3(1), 239–246. https://publikasi.medikasuherman.ac.id/index.php/cmj

Arwinda, N., Rahmawati, D., & Supriyadi, A. (2024). Medication adherence and cardiovascular risk among hypertensive patients in primary care: A cross-sectional analysis. Journal of Primary Health, 12(2), 55–63.

Cahyani, R., & Widyastuti, S. (2022). Hubungan kepatuhan minum obat dengan pengendalian tekanan darah pada pasien hipertensi di Puskesmas. Jurnal Kesehatan Masyarakat, 18(3), 201–210.

DiMatteo, M.R. (2004). Social Support and Patient Adherence to Medical Treatment.

Goldberger, Z.D., Hahn, E.J., et al. (2019). 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Journal of the American College of Cardiology, 74(10), e177–e232.

DiMatteo, M.R. (2004). Social Support and Patient Adherence to Medical Treatment.

Goldberger, Z.D., Hahn, E.J., et al. (2019). 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Journal of the American College of Cardiology, 74(10), e177–e232.

Jin, J., et al. (2008). Factors affecting therapeutic compliance.

Kemenkes RI. (2019). Profil Kesehatan Indonesia.

Krousel-Wood, M., Thomas, S., Muntner, P., & Morisky, D. (2015). Medication Adherence: A Key Factor in Achieving Blood Pressure Control and Good Clinical Outcomes in Hypertensive Patients. Current Opinion in Cardiology, 25(4), 311–315.

Riskesdas. (2018). Laporan Nasional Riset Kesehatan Dasar.

Sofyan, O., Wijaya, A., Azzahra, F., Rissa, M. M., Yulianto, D., & Sa’adah, H. (2022). Penyuluhan Pencegahan Hipertensi Dengan Cerdik. Jurnal Bakti Untuk Negeri, 2(2), 140–143. https://ejurnal.stikesisfi.ac.id/index.php/JBN/article/view/1293

Suprayitno, E, Purnomo, J. D. T., Sutikno, S., & Indriyani, R. (2020). Health education in principle of community affected teenagaer’s smooking attitude and habitual in the coastal area of madura island indonesia. International Journal of Psychosocial Rehabilitation, 24(10), 1492– 1502.

Vrijens, B., et al. (2012). A new taxonomy for describing and defining adherence to medications.

WHO. (2023). Global Report on Hypertension.

Published
2025-12-28